IL6 and Parkinson disease: An association between increased levels of IL-6 and worse cognitive performance has been shown in patients with Parkinson’s disease (PD) and dementia [24] (a condition resembling DLB in regard to neuropathological changes and symptoms [23]) and patients with PD with cognitive impairment [18].